Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neurodegenerative Disease
Power3 Medical's Dr. Ira Goldknopf's Editorial Published in Expert Review of Proteomics
March 18th, 2008
Power3 Medical Products, Inc's (OTCBB: PWRM, http://www.power3medical.com) director of proteomics, Dr. Ira Goldknopf, has published an invited editorial in the February 2008 issue of Expert Review of Proteomics. Power3 Medical is a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases. The editorial, entitled "Blood Based Proteomics for Personalized Medicine, Examples From Neurodegenerative Disease," outlines how "proteins in the blood serum can tell us what disease pathways and mechanisms...are active in patients." In his editorial, Dr. Goldknopf cited...
Source: Cancer Weekly (2008-03-18)
|
